Inhibition of co-colonizing cystic fibrosis-associated pathogens by Pseudomonas aeruginosa and Burkholderia multivorans
Cystic fibrosis (CF) is a recessive genetic disease characterized by chronic respiratory infections and inflammation causing permanent lung damage. Recurrent infections are caused by Gram-negative antibiotic-resistant bacterial pathogens such as Pseudomonas aeruginosa, Burkholderia cepacia complex (...
| Main Authors: | Costello, A., Reen, F., O'Gara, Fergal, Callaghan, M., McLean, S. |
|---|---|
| Format: | Journal Article |
| Published: |
Society for General Microbiology
2014
|
| Online Access: | http://hdl.handle.net/20.500.11937/11588 |
Similar Items
Statins inhibit in vitro virulence phenotypes of Pseudomonas aeruginosa
by: Hennessey, E., et al.
Published: (2013)
by: Hennessey, E., et al.
Published: (2013)
Airway infection and Pseudomonas aeruginosa in bronchiectasis (cystic fibrosis and non-cystic fibrosis bronchiectasis)
by: Webb, Karmel
Published: (2022)
by: Webb, Karmel
Published: (2022)
Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis
by: Palser, Sally C.
Published: (2024)
by: Palser, Sally C.
Published: (2024)
Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)
by: Hurley, M.N., et al.
Published: (2012)
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
by: Langton Hewer, Simon C., et al.
Published: (2014)
by: Langton Hewer, Simon C., et al.
Published: (2014)
Identification and characterization of Burkholderia multivorans CCA53
by: Akita, Hironaga, et al.
Published: (2017)
by: Akita, Hironaga, et al.
Published: (2017)
Direct and Rapid Electrochemical Detection of Pseudomonas aeruginosa Quorum Signaling Molecules in Bacterial Cultures and Cystic Fibrosis Sputum Samples through Cationic Surfactant-Assisted Membrane Disruption
by: Buzid, A., et al.
Published: (2017)
by: Buzid, A., et al.
Published: (2017)
Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis
by: Barr, Helen L., et al.
Published: (2015)
by: Barr, Helen L., et al.
Published: (2015)
Analogues of Pseudomonas aeruginosa signalling molecules to tackle infections
by: Ó Muimhneacháin, E., et al.
Published: (2018)
by: Ó Muimhneacháin, E., et al.
Published: (2018)
Lectin-mediated biofilm maturation, quorum sensing and Pseudomonas aeruginosa infections in cystic fibrosis
by: Crusz, S.A.
Published: (2009)
by: Crusz, S.A.
Published: (2009)
Low oxygen induces the type III secretion system in Pseudomonas aeruginosa via modulation of the small RNAs rsmZ and rsmY
by: O'Callaghan, J., et al.
Published: (2011)
by: O'Callaghan, J., et al.
Published: (2011)
Subinhibitory concentrations of the cationic antimicrobial peptide colistin induce the pseudomonas quinolone signal in Pseudomonas aeruginosa
by: Cummins, J., et al.
Published: (2009)
by: Cummins, J., et al.
Published: (2009)
The requirements at the C-3 position of alkylquinolones for signalling in Pseudomonas aeruginosa
by: Shanahan, R., et al.
Published: (2017)
by: Shanahan, R., et al.
Published: (2017)
Molecular evolution of LysR-type transcriptional regulation in Pseudomonas aeruginosa
by: Reen, F., et al.
Published: (2013)
by: Reen, F., et al.
Published: (2013)
Genetic analysis of genes involved in dipeptide metabolism and cytotoxicity in Pseudomonas aeruginosa PAO1
by: Kiely, P., et al.
Published: (2008)
by: Kiely, P., et al.
Published: (2008)
Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis
by: Gilchrist, Francis J., et al.
Published: (2015)
by: Gilchrist, Francis J., et al.
Published: (2015)
HOST DEFENCE PEPTIDE AS AN INNOVATIVE NOVEL THERAPY FOR PSEUDOMONAS AERUGINOSA BIOFILM INFECTIONS IN THE CYSTIC FIBROSIS LUNG
by: Wannigama, D., et al.
Published: (2019)
by: Wannigama, D., et al.
Published: (2019)
Surviving and thriving in the cystic fibrosis lung: contribution of an arginine specific aminopeptidase to sustained infection by Pseudomonas aeruginosa
by: Spencer, Daniella Lucy
Published: (2019)
by: Spencer, Daniella Lucy
Published: (2019)
A new regulator of pathogenicity (bvlR) is required for full virulence and tight microcolony formation in Pseudomonas aeruginosa
by: McCarthy, R., et al.
Published: (2014)
by: McCarthy, R., et al.
Published: (2014)
Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans
by: McAlester, G., et al.
Published: (2008)
by: McAlester, G., et al.
Published: (2008)
A novel host-responsive sensor mediates virulence and type III secretion during Pseudomonas aeruginosa-host cell interactions
by: O'Callaghan, J., et al.
Published: (2012)
by: O'Callaghan, J., et al.
Published: (2012)
A non-classical LysR-type transcriptional regulator PA2206 is required for an effective oxidative stress response in Pseudomonas aeruginosa.
by: Reen, F, et al.
Published: (2013)
by: Reen, F, et al.
Published: (2013)
The Impact of Simvastatin on Pulmonary Effectors of Pseudomonas aeruginosa Infection
by: Hennessy, E., et al.
Published: (2014)
by: Hennessy, E., et al.
Published: (2014)
Rapid Electrochemical Detection of Pseudomonas aeruginosa Signaling Molecules by Boron-Doped Diamond Electrode
by: Buzid, A., et al.
Published: (2018)
by: Buzid, A., et al.
Published: (2018)
Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection
by: Darch, Sophie E., et al.
Published: (2015)
by: Darch, Sophie E., et al.
Published: (2015)
Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative study
by: Palser, Sally C., et al.
Published: (2016)
by: Palser, Sally C., et al.
Published: (2016)
Elucidating and Utilising the Mechanisms Used by Pseudomonas
aeruginosa to Develop Resistance to Bacteriophages to Aid
Therapeutic Formulation and Application in Cystic Fibrosis
by: Vaitekenas, Andrew
Published: (2023)
by: Vaitekenas, Andrew
Published: (2023)
Pseudomonas aeruginosa RsmA plays an important role during murine infection by influencing colonization, virulence, persistence, and pulmonary inflammation
by: Mulcahy, H., et al.
Published: (2008)
by: Mulcahy, H., et al.
Published: (2008)
Can aerosolised bacteriophage preparations against Pseudomonas aeruginosa protect against endotoxin-mediated inflammation in the lungs of people with cystic fibrosis?
by: Trend, S., et al.
Published: (2016)
by: Trend, S., et al.
Published: (2016)
Aspirated bile: a major host trigger modulating respiratory pathogen colonisation in cystic fibrosis patients
by: Reen, F., et al.
Published: (2014)
by: Reen, F., et al.
Published: (2014)
Control of attachment of Pseudomonas aeruginosa and Burkholderia cepacia to surfaces by shear force
by: Hui, Y., et al.
Published: (2016)
by: Hui, Y., et al.
Published: (2016)
One step preparation and electrochemical analysis of IQS, a cell–cell communication signal in the nosocomial pathogen Pseudomonas aeruginosa
by: Shang, F., et al.
Published: (2014)
by: Shang, F., et al.
Published: (2014)
Cystic Fibrosis isolates of Pseudomonas aeruginosa retain iron-regulated antimicrobial activity against Staphylococcus aureus through the action of multiple alkylquinolones
by: Nguyen, Angela T., et al.
Published: (2016)
by: Nguyen, Angela T., et al.
Published: (2016)
The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways
by: Trend, S., et al.
Published: (2017)
by: Trend, S., et al.
Published: (2017)
POLYMICROBIAL INFECTION AND NEUTROPHILIC DISEASE IN CYSTIC FIBROSIS AIRWAYS
by: Laucirica, D.R., et al.
Published: (2019)
by: Laucirica, D.R., et al.
Published: (2019)
Research Protocol - Effect of anti-staphylococcal antibiotic prophylaxis upon isolation and colonisation with Staphylococcus aureus, Pseudomonas aeruginosa and their resistant variants in cystic fibrosis
by: Hurley, Matthew, et al.
Published: (2016)
by: Hurley, Matthew, et al.
Published: (2016)
Pseudomonas aeruginosa Alkyl quinolones repress hypoxia-inducible factor 1 (HIF-1) signaling through HIF-1a degradation
by: Legendre, C., et al.
Published: (2012)
by: Legendre, C., et al.
Published: (2012)
Impaired expression of hypoxia-inducible factor-1a in cystic fibrosis airway epithelial cells - A role for HIF-1 in the pathophysiology of CF?
by: Legendre, C., et al.
Published: (2011)
by: Legendre, C., et al.
Published: (2011)
Neutrophil Elastase Activity During Episodes Of Pseudomonas Infection In Early Cystic Fibrosis
by: Garratt, L.W., et al.
Published: (2016)
by: Garratt, L.W., et al.
Published: (2016)
Synthesis and electrochemical detection of a thiazolyl-indole natural product isolated from the nosocomial pathogen Pseudomonas aeruginosa
by: Buzid, A., et al.
Published: (2016)
by: Buzid, A., et al.
Published: (2016)
Similar Items
-
Statins inhibit in vitro virulence phenotypes of Pseudomonas aeruginosa
by: Hennessey, E., et al.
Published: (2013) -
Airway infection and Pseudomonas aeruginosa in bronchiectasis (cystic fibrosis and non-cystic fibrosis bronchiectasis)
by: Webb, Karmel
Published: (2022) -
Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis
by: Palser, Sally C.
Published: (2024) -
Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012) -
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
by: Langton Hewer, Simon C., et al.
Published: (2014)